Association of plasma potassium with risk of developing chronic kidney disease defined as eGFRcreatinine-cystatin C <60 ml/min/1.73m2 or urinary albumin excretion >30 mg/24h in 5,130 participants of the Prevention of Renal and Vascular End-Stage Disease (PREVEND) study. This evidence concerns the gene CST3 and chronic kidney disease.